References
- BellBGSchellevisFStobberinghEGoossensHPringleMA systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistanceBMC Infect Dis2014141324405683
- OzerBOzbakıs AkkurtBCDuranNOnlenYSavasLTurhanogluSEvaluation of nosocomial infections and risk factors in critically ill patientsMed Sci Monit2011173H17H22
- BereketWHemalathaKGetenetBUpdate on bacterial nosocomial infectionsEur Rev Med Pharmacol Sci20121681039104422913154
- RayGTSuayaJABaxterRIncidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based studyBMC Infect Dis20131325223721377
- WatkinsRRDavidMZSalataRACurrent concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureusJ Med Microbiol201261pt 91179119322745137
- van BelkumAMellesDCNouwenJCo-evolutionary aspects of human colonisation and infection by Staphylococcus aureusInfect Genet Evol200991324719000784
- MoneckeSCoombsGShoreACA field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureusPLoS One201164e1793621494333
- JonesAMDoddMEMorrisJDohertyCGovanJRWebbAKClinical outcome for cystic fibrosis patients infected with transmissible Pseudomonas aeruginosa: an 8-year prospective studyChest201013761405140920081099
- GangRKBangRLSanyalSCMokaddasELariARPseudomonas aeruginosa septicaemia in burnsBurns199925761161610563687
- KluytmansJAMoutonJWIjzermanEPNasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgeryJ Infect Dis199517112162197798667
- MulcahyLRIsabellaVMLewisKPseudomonas aeruginosa biofilms in diseaseMicrob Ecol201468111224096885
- HuhAJKwonYJ“Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant eraJ Control Release2011156212814521763369
- NiemirowiczKMarkiewiczKHWilczewskaAZCarHMagnetic nanoparticles as new diagnostic tools in medicineAdv Med Sci201257219620723154427
- WilczewskaAZNiemirowiczKMarkiewiczKHCarHNanoparticles as drug delivery systemsPharmacol Rep20126451020103723238461
- ChomouckaJDrbohlavovaJHuskaDAdamVKizekRHubalekJMagnetic nanoparticles and targeted drug deliveringPharmacol Res201062214414920149874
- LaurentSDutzSHäfeliUOMahmoudiMMagnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticlesAdv Colloid Interface Sci20111661–282321601820
- NiemirowiczKSwiecickaIWilczewskaAZGold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosaInt J Nanomedicine201492217222424855358
- NiemirowiczKSwiecickaIWilczewskaAZGrowth arrest and rapid capture of select pathogens following magnetic nanoparticle treatmentColloids Surf B Biointerfaces2015131293825942700
- GhoshINPatilSDSharmaTKSrivastavaSKPathaniaRNavaniNKSynergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applicationsInt J Nanomedicine201384721473124376352
- BrownANSmithKSamuelsTALuJObareSOScottMENanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureusAppl Environ Microbiol20127882768277422286985
- LiLHYenMYHoCCNon-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeaePLoS One201385e6479423705013
- JenaPMohantySMallickRJacobBSonawaneAToxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cellsInt J Nanomedicine201271805181822619529
- RudenSHilpertKBerditschMWadhwaniPUlrichASSynergistic interaction between silver nanoparticles and membrane-permeabilizing antimicrobial peptidesAntimicrob Agents Chemother20095383538354019528287
- NaqviSZKiranUAliMICombined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteriaInt J Nanomedicine201383187319523986635
- RaiMKDeshmukhSDIngleAPGadeAKSilver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteriaJ Appl Microbiol2012112584185222324439
- FayazAMBalajiKGirilalMYadavRKalaichelvanPTVenketesanRBiogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteriaNanomedicine20106110310919447203
- GurunathanSHanJWKwonDNKimJHEnhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteriaNanoscale Res Lett20149137325136281
- MassartRPreparation of aqueous magnetic liquids in alkaline and acidic mediaIEEE Trans Magn198117212471248
- WilczewskaAMarkiewiczKSurface-initiated RAFT/MADIX polymerization on Xanthate-coated iron oxide nanoparticlesMacromol Chem Phys20142152190197
- TimurkaynakFCanFAzapOKDemirbilekMArslanHKaramanSOIn vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care unitsInt J Antimicrob Agents200627322422816464562
- KahJCYPhonthammachaiNWanRCYSynthesis of gold nanoshells based on the deposition-precipitation processGold Bull20084112336
- Hussein-Al-AliSHEl ZowalatyMEHusseinMZIsmailMWebsterTJSynthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibioticInt J Nanomedicine2014954955724549109
- ReddyAJKokilaMKNagabhushanaHCombustion synthesis, characterization and Raman studies of ZnO nanopowdersSpectrochim Acta A Mol Biomol Spectrosc2011811535821764361
- KadurugamuwaJLSinLAlbertEDirect continuous method for monitoring biofilm infection in a mouse modelInfect Immun200371288289012540570
- WnorowskaUWątekMDurnaśBExtracellular DNA as an essential component and therapeutic target of microbial biofilmStud Med2015312132138
- BuckiRLeszczynskaKNamiotASokolowskiWCathelicidin LL-37: a multitask antimicrobial peptideArch Immunol Ther Exp (Warsz)2010581152520049649
- ZasloffMMagainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursorProc Natl Acad Sci U S A19878415544954533299384
- BuckiRPastoreJJRandhawaPVegnersRWeinerDJJanmeyPAAntibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittinAntimicrob Agents Chemother20044851526153315105101
- MooreKSWehrliSRoderHSqualamine: an aminosterol antibiotic from the sharkProc Natl Acad Sci U S A1993904135413588433993
- IsogaiEIsogaiHTakahashiKOkumuraKSavagePBCeragenin CSA-13 exhibits antimicrobial activity against cariogenic and periodontopathic bacteriaOral Microbiol Immunol200924217017219239645
- Bozkurt-GuzelCSavagePBAkcaliAOzbek-CelikBPotential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patientsBiomed Res Int2014201471027324804236
- NagantCPittsBStewartPSFengYSavagePBDehayeJPStudy of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosaMicrobiologyopen20132231832523436807
- LeszczynskaKNamiotDByfieldFJAntibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infectionsJ Antimicrob Chemother201368361061823134677
- SavagePBLiCTaotafaUDingBGuanQAntibacterial properties of cationic steroid antibioticsFEMS Microbiol Lett200221711712445638
- ChinJNRybakMJCheungCMSavagePBAntimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureusAntimicrob Agents Chemother20075141268127317210765
- ChinJNJonesRNSaderHSSavagePBRybakMJPotential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosaJ Antimicrob Chemother200861236537018079128
- LaiXZFengYPollardJCeragenins: cholic acid-based mimics of antimicrobial peptidesAcc Chem Res200841101233124018616297
- IstrateCMHolbanAMGrumezescuAMIron oxide nanoparticles modulate the interaction of different antibiotics with cellular membranesRom J Morphol Embryol201455384985625329111
- GrumezescuAMGestalMCHolbanAMBiocompatible Fe3O4 increases the efficacy of amoxicillin delivery against Gram-positive and Gram-negative bacteriaMolecules20141945013502724759068
- GuHHoPLTongEWangLXuBPresenting vancomycin on nanoparticles to enhance antimicrobial activitiesNano Lett20033912611263
- MaloneMECorriganOIKavanaghPVGowingCDonnellyMD’ArcyDMPharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltrationInt J Antimicrob Agents201342433534223920093
- LeubaKDDurmusNGTaylorENWebsterTJShort communication: carboxylate functionalized superparamagnetic iron oxide nanoparticles (SPION) for the reduction of S. aureus growth post biofilm formationInt J Nanomedicine2013873173623450111
- KurodaKFukudaTOkumuraKCeragenin CSA-13 induces cell cycle arrest and antiproliferative effects in wild-type and p53 null mutant HCT116 colon cancer cellsAnticancer Drugs201324882683423817390
- BuckiRSostareczAGByfieldFJSavagePBJanmeyPAResistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputumJ Antimicrob Chemother200760353554517584802
- BuckiRNiemirowiczKWnorowskaUPolyelectrolyte-mediated increase of biofilm mass formationBMC Microbiol20151511726048182
- ChatterjeeSMaitiPDeyRKunduABiofilms on indwelling urologic devices: microbes and antimicrobial management prospectAnn Med Health Sci Res20144110010424669340
- OlsenIBiofilm-specific antibiotic tolerance and resistanceEur J Clin Microbiol Infect Dis201534587788625630538
- PoletaevABouraPThe immune system, natural autoantibodies and general homeostasis in health and diseaseHippokratia201115429529824391407
- LeszczyńskaKNamiotACruzKPotential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infectionsJ Appl Microbiol2011110122923820961363
- SinghPKTackBFMcCrayPBWelshMJSynergistic and additive killing by antimicrobial factors found in human airway surface liquidAm J Physiol Lung Cell Mol Physiol20002795L799L80511053013
- Bozkurt-GuzelCSavagePBGercekerAAIn vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patientsChemotherapy201157650551022286090